By Tarun Sai Lomte A comprehensive review of nearly 130 studies shows the strongest evidence to date that “forever chemicals” ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare ...

NotebookLM is the wrong tool for money ...

The Company’s abstract, Evaluation of Teverelix in Healthy Female Volunteers, has been accepted for presentation at American ...

JOHANNESBURG, SOUTH AFRICA | Xinhua | In July 2025, braving Typhoon Co-may’s gales, a planeload of 20 Zhejiang Normal ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing ...

The novel oral selective estrogen receptor (ER) degrader giredestrant significantly reduced the risk of invasive disease ...

As bureaucratic hurdles limit access to records in the country, researchers are forced to navigate a labyrinth of protocols ...

Important deadlines include February 1 and March 1, 2026, for abstract submissions, and April 12, 2026, for early-bird ...

When the United States recently escalated its confrontation with Venezuela – carrying out strikes in Caracas and capturing ...

By Hugo Francisco de Souza By analyzing millions of patients worldwide, researchers reveal consistent patterns in Long COVID ...

Now that artificial intelligence can imitate an individual’s writing style, voice, and even artworks, issues of authenticity ...